Ocean Return On Assets from 2010 to 2024

OCEAW Stock   0.04  0  9.77%   
Ocean Biomedical Return On Assets yearly trend continues to be fairly stable with very little volatility. Return On Assets are likely to outpace its year average in 2024. Return On Assets is a profitability ratio that indicates the percentage of profit Ocean Biomedical earns in relation to its overall resources. It is calculated by dividing net income by total assets. View All Fundamentals
 
Return On Assets  
First Reported
2010-12-31
Previous Quarter
0.004589
Current Value
0.004818
Quarterly Volatility
202.90053658
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ocean Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocean Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Selling General Administrative of 10.4 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 3.44 or Days Sales Outstanding of 0.0. Ocean financial statements analysis is a perfect complement when working with Ocean Biomedical Valuation or Volatility modules.
  
Check out the analysis of Ocean Biomedical Correlation against competitors.
For more information on how to buy Ocean Stock please use our How to Invest in Ocean Biomedical guide.

Latest Ocean Biomedical's Return On Assets Growth Pattern

Below is the plot of the Return On Assets of Ocean Biomedical over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Ocean Biomedical's Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocean Biomedical's overall financial position and show how it may be relating to other accounts over time.
Return On Assets10 Years Trend
Pretty Stable
   Return On Assets   
       Timeline  

Ocean Return On Assets Regression Statistics

Arithmetic Mean(55.75)
Geometric Mean1.56
Coefficient Of Variation(363.94)
Mean Deviation97.79
Median(4.28)
Standard Deviation202.90
Sample Variance41,169
Range789
R-Value(0.24)
Mean Square Error41,759
R-Squared0.06
Significance0.39
Slope(10.94)
Total Sum of Squares576,361

Ocean Return On Assets History

2024 0.004818
2023 0.004589
2022 0.005098
2021 -789.16

About Ocean Biomedical Financial Statements

Ocean Biomedical investors use historical fundamental indicators, such as Ocean Biomedical's Return On Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ocean Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ocean Stock Analysis

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.